Biotechnology Market Size, Share & Trends Analysis By Technology (DNA Sequencing, Fermentation), By Application (Health, Bioinformatics), By Region (North America, EU, APAC), And Segment Forecasts, 2022 - 2030
This report can be delivered to the clients within 3 Business Days
Biotechnology Market Growth & Trends
The global biotechnology market size is expected to reach USD 3,879.51 billion by 2030, registering a CAGR of 13.9% over the forecast period, according to a new report by Grand View Research, Inc. The market is driven by factors including the advent of innovative and advanced technologies, significant investments & government initiatives favoring the biotechnology industry, and rising demand for synthetic biology applications. Biotechnology startups are acquiring robust funding support and venture capital investments, which, in 2021, amounted to USD 41 billion; an increase of over 11% as compared to the previous year’s USD 36.7 billion. Notable funding rounds included Caris Life Sciences’ $830 million in May 2021 for its precision medicine platform expansion, Abogen’s $700 million Series C funding in August 2021 for its COVID-19 vaccine candidate’s clinical development, & ElevateBio’s $525 million Series C funding in March 2021 for advancing its cell & gene therapy technologies.
In addition, 28 new biotech unicorns were created in 2021, leading to a total of 192 unicorns present in the sector. Government support for the development of biotechnological infrastructure is also contributing to market growth. For instance, India’s Union Budget 2021-22 consisted of a provision of USD 227.94 million for biotechnology R&D, along with plans for the setting up of nine biosafety level-3 laboratories in the country. Furthermore, initiatives, such as Illumina Accelerator, are providing access to seed investment, genomics expertise, and Illumina sequencing systems & reagents to selected emerging companies and propelling the market growth.
Due to the COVID-19 pandemic, novel solutions are being explored in the development of vaccines & diagnostic tools for combating the disease. For instance, the advent of mRNA vaccines was supported by cutting-edge technologies in the biotechnology sector, including molecular research tools & genetic sequencing methods that accelerated the timelines for vaccine development. Furthermore, in March 2022, the Diagnostic Analyzer for Specific Hybridization (DASH), a highly sensitive and easy-to-perform PCR test for COVID-19, received FDA emergency use authorization. The test is commercialized by Minute Molecular Diagnostics and can deliver results within 15 minutes. Such advancements in molecular diagnostics are expected to fuel market growth.
Biotechnology Market Report Highlights
Biotechnology Market Growth & Trends
The global biotechnology market size is expected to reach USD 3,879.51 billion by 2030, registering a CAGR of 13.9% over the forecast period, according to a new report by Grand View Research, Inc. The market is driven by factors including the advent of innovative and advanced technologies, significant investments & government initiatives favoring the biotechnology industry, and rising demand for synthetic biology applications. Biotechnology startups are acquiring robust funding support and venture capital investments, which, in 2021, amounted to USD 41 billion; an increase of over 11% as compared to the previous year’s USD 36.7 billion. Notable funding rounds included Caris Life Sciences’ $830 million in May 2021 for its precision medicine platform expansion, Abogen’s $700 million Series C funding in August 2021 for its COVID-19 vaccine candidate’s clinical development, & ElevateBio’s $525 million Series C funding in March 2021 for advancing its cell & gene therapy technologies.
In addition, 28 new biotech unicorns were created in 2021, leading to a total of 192 unicorns present in the sector. Government support for the development of biotechnological infrastructure is also contributing to market growth. For instance, India’s Union Budget 2021-22 consisted of a provision of USD 227.94 million for biotechnology R&D, along with plans for the setting up of nine biosafety level-3 laboratories in the country. Furthermore, initiatives, such as Illumina Accelerator, are providing access to seed investment, genomics expertise, and Illumina sequencing systems & reagents to selected emerging companies and propelling the market growth.
Due to the COVID-19 pandemic, novel solutions are being explored in the development of vaccines & diagnostic tools for combating the disease. For instance, the advent of mRNA vaccines was supported by cutting-edge technologies in the biotechnology sector, including molecular research tools & genetic sequencing methods that accelerated the timelines for vaccine development. Furthermore, in March 2022, the Diagnostic Analyzer for Specific Hybridization (DASH), a highly sensitive and easy-to-perform PCR test for COVID-19, received FDA emergency use authorization. The test is commercialized by Minute Molecular Diagnostics and can deliver results within 15 minutes. Such advancements in molecular diagnostics are expected to fuel market growth.
Biotechnology Market Report Highlights
- The health application segment accounted for the largest share in 2021 due to high disease prevalence, increasing focus on regenerative medicines, innovations in technologies fueled by the COVID-19 pandemic, and improvements in healthcare infrastructure
- The DNA sequencing technology segment accounted for the second-largest share in 2021 as a result of declining costs of sequencing and its increasing adoption in precision medicine development
- North America held the largest share of the global market in 2021 owing to the launch of advanced biotechnological solutions facilitated by key players operating in the region
- Asia Pacific is expected to register the fastest CAGR from 2022 to 2030 due to promising government initiatives and favorable regulatory changes in drug approval processes in India and China
CHAPTER 1 METHODOLOGY AND SCOPE
1.1 Research Assumptions
1.2 Research Methodology
1.3 Information Procurement
1.4 Information or Data Analysis
1.5 Market Formulation and Validation
1.6 Global Market: CAGR Calculation
1.7 Objectives
1.7.1 Objective
1.7.2 Objective
1.8 Revenue Modeling: Post-COVID-19 Market Scenario
1.8.1 Present market dynamics assessment: Company evaluation
1.8.2 Market dynamics assessment: future projections
1.8.3 Top 20 operational entities: Company revenue & market value analysis
1.8.3.1 Part A
1.8.3.2 Part B
1.8.3.3 Part C
CHAPTER 2 EXECUTIVE SUMMARY
2.1 Market Snapshot
CHAPTER 3 MARKET VARIABLES, TRENDS, AND SCOPE
3.1 Market Trends and Outlook
3.2 Market Segmentation and Scope
3.3 Market Dynamics
3.3.1 Market driver analysis
3.3.1.1 Presence of favorable government initiatives
3.3.1.2 Rising demand for agro-based products
3.3.1.3 Growing demand for synthetic biology
3.3.1.4 Declining prices of DNA sequencing
3.3.1.5 Growing healthcare expenditure boosting development of effective personalized diagnostic & therapeutic procedures for cancer
3.3.2 Market restraint analysis
3.3.2.1 Ethical & legal limitations
3.3.2.2 Risks associated with GM organisms and crops
3.3.2.3 Challenges associated with NGS implementation
3.4 Penetration and Growth Prospect Mapping for Technology, 2021
3.5 Market Share Analysis, 2021
3.6 Business Environment Analysis
3.6.1 SWOT Analysis; By factor (Political & Legal, Economic and Technological)
3.6.2 Porter’s Five Forces Analysis
CHAPTER 4 BIOTECHNOLOGY CATEGORIZATION: APPLICATION ESTIMATES & TREND ANALYSIS
4.1 Biotechnology Market: Application Movement Analysis
4.2 Health
4.2.1 Pre-COVID Segment Scenario
4.2.2 Post-COVID Segment Scenario
4.2.3 Global health Biotechnology market, 2018 - 2030 (USD Billion)
4.3 Food & Agriculture
4.3.1 Pre-COVID Segment Scenario
4.3.2 Post-COVID Segment Scenario
4.3.3 Global Food & Agriculture Biotechnology market, 2018 - 2030 (USD Billion)
4.4 Natural Resources & Environment
4.4.1 Pre-COVID Segment Scenario
4.4.2 Post-COVID Segment Scenario
4.4.3 Global Natural resources & environment Biotechnology market, 2018 - 2030 (USD Billion)
4.5 Industrial Processing
4.5.1 Pre-COVID Segment Scenario
4.5.2 Post-COVID Segment Scenario
4.5.3 Global Industrial processing Biotechnology market, 2018 - 2030 (USD Billion)
4.6 Bioinformatics
4.6.1 Pre-COVID Segment Scenario
4.6.2 Post-COVID Segment Scenario
4.6.3 Global Bioinformatics Biotechnology market, 2018 - 2030 (USD Billion)
4.7 Other Applications
4.7.1 Global Biotechnology market for applications, 2018 - 2030 (USD Billion)
CHAPTER 5 BIOTECHNOLOGY MARKET CATEGORIZATION: TECHNOLOGY ESTIMATES & TREND ANALYSIS
5.1 Biotechnology Market: Technology Movement Analysis
5.2 DNA Sequencing
5.2.1 Pre-COVID Segment Scenario
5.2.2 Post-COVID Segment Scenario
5.2.3 Global Biotechnology market for DNA Sequencing, 2018 - 2030 (USD Billion)
5.3 Nanobiotechnology
5.3.1 Pre-COVID Segment Scenario
5.3.2 Post-COVID Segment Scenario
5.3.3 Global Biotechnology market for Nanobiotechnology, 2018 - 2030 (USD Billion)
5.4 Tissue Engineering & Regeneration
5.4.1 Pre-COVID Segment Scenario
5.4.2 Post-COVID Segment Scenario
5.4.3 Global Biotechnology market for Tissue engineering and regeneration, 2018 - 2030 (USD Billion)
5.5 Fermentation
5.5.1 Pre-COVID Segment Scenario
5.5.2 Post-COVID Segment Scenario
5.5.3 Biopharmaceutical Manufacturing
5.5.4 Biopharmaceutical & Biotechnology Research
5.5.5 Others
5.5.6 Global Biotechnology market for Fermentation, 2018 - 2030 (USD Billion)
5.6 Cell-based Assays
5.6.1 Pre-COVID Segment Scenario
5.6.2 Post-COVID Segment Scenario
5.6.3 Global Biotechnology market for Cell-based assays, 2018 - 2030 (USD Billion)
5.7 PCR Technology
5.7.1 Pre-COVID Segment Scenario
5.7.2 Post-COVID Segment Scenario
5.7.3 Global Biotechnology market for PCR technology, 2018 - 2030 (USD Billion)
5.8 Chromatography
5.8.1 Pre-COVID Segment Scenario
5.8.2 Post-COVID Segment Scenario
5.8.3 Global Biotechnology market for Chromatography, 2018 - 2030 (USD Billion)
5.9 Other Technologies
5.9.1 Pre-COVID Segment Scenario
5.9.2 Post-COVID Segment Scenario
5.9.3 Global Biotechnology market for Other technologies, 2018 - 2030 (USD Billion)
CHAPTER 6 BIOTECHNOLOGY MARKET CATEGORIZATION: REGIONAL ESTIMATES & TREND ANALYSIS, BY APPLICATION & TECHNOLOGY
6.1 Biotechnology Share by Regional, 2021 & 2030
6.2 North America
6.2.1 U.S.
6.2.2 Canada
6.3 Europe
6.3.1Germany
6.3.2 U.K.
6.3.3 France
6.3.4 Italy
6.3.5 Spain
6.4 Asia-Pacific
6.4.1 Japan
6.4.2 China
6.4.3 India
6.4.4 South Korea
6.4.5 Australia
6.5 Latin America
6.5.1 Brazil
6.5.2 Mexico
6.6 Middle East and Africa (MEA)
6.6.1 South Africa
6.6.2 Saudi Arabia
CHAPTER 7 COMPETITIVE LANDSCAPE
7.1 Strategy Framework
7.2 Company Profiles
7.2.1 AstraZeneca
7.2.1.1 Company Overview
7.2.1.2 Financial Performance
7.2.1.3 Product Benchmarking
7.2.1.4 Strategic Initiatives
7.2.2 Gilead Sciences Inc.
7.2.2.1 Company Overview
7.2.2.2 Financial Performance
7.2.2.3 Product Benchmarking
7.2.2.4 Strategic Initiatives
7.2.3 Bristol-Myers Squibb
7.2.3.1 Company Overview
7.2.3.1.1 Celgene Corporation
7.2.3.2 Financial Performance
7.2.3.3 Product Benchmarking
7.2.3.4 Strategic Initiatives
7.2.4 Biogen
7.2.4.1 Company Overview
7.2.4.2 Financial Performance
7.2.4.3 Product Benchmarking
7.2.4.4 Strategic Initiatives
7.2.5 Abbott Laboratories
7.2.5.1 Company Overview
7.2.5.2 Financial Performance
7.2.5.3 Product Benchmarking
7.2.5.4 Strategic Initiatives
7.2.6 Amgen Inc.
7.2.6.1 Company Overview
7.2.6.2 Financial Performance
7.2.6.3 Product Benchmarking
7.2.6.4 Strategic Initiatives
7.2.7 Novo Nordisk A/S
7.2.7.1 Company Overview
7.2.7.2 Financial Performance
7.2.7.3 Product Benchmarking
7.2.7.4 Strategic Initiatives
7.2.8 Merck KGaA
7.2.8.1 Company Overview
7.2.8.2 Financial Performance
7.2.8.3 Product Benchmarking
7.2.8.4 Strategic Initiatives
7.2.9 Johnson & Johnson Services
7.2.9.1 Company Overview
7.2.9.2 Financial Performance
7.2.9.3 Product Benchmarking
7.2.9.4 Strategic Initiatives
7.2.10 Novartis AG
7.2.10.1 Company Overview
7.2.10.2 Financial Performance
7.2.10.3 Product Benchmarking
7.2.10.4 Strategic Initiatives
7.2.11 Sanofi
7.2.11.1 Company overview
7.2.11.1.1 Genzyme
7.2.11.2 Financial Performance
7.2.11.3 Product Benchmarking
7.2.11.4 Strategic Initiatives
7.2.12 F. Hoffmann-La Roche Ltd.
7.2.12.1 Company Overview
7.2.12.2 Financial Performance
7.2.12.3 Product Benchmarking
7.2.12.4 Strategic Initiatives
7.2.13 Pfizer Inc.
7.2.13.1 Company overview
7.2.13.2 Financial Performance
7.2.13.3 Product Benchmarking
7.2.13.4 Strategic Initiatives
7.2.14 Lonza
7.2.14.1 Company Overview
7.2.14.2 Financial Performance
7.2.14.3 Product Benchmarking
7.2.14.4 Strategic Initiatives
1.1 Research Assumptions
1.2 Research Methodology
1.3 Information Procurement
1.4 Information or Data Analysis
1.5 Market Formulation and Validation
1.6 Global Market: CAGR Calculation
1.7 Objectives
1.7.1 Objective
1.7.2 Objective
1.8 Revenue Modeling: Post-COVID-19 Market Scenario
1.8.1 Present market dynamics assessment: Company evaluation
1.8.2 Market dynamics assessment: future projections
1.8.3 Top 20 operational entities: Company revenue & market value analysis
1.8.3.1 Part A
1.8.3.2 Part B
1.8.3.3 Part C
CHAPTER 2 EXECUTIVE SUMMARY
2.1 Market Snapshot
CHAPTER 3 MARKET VARIABLES, TRENDS, AND SCOPE
3.1 Market Trends and Outlook
3.2 Market Segmentation and Scope
3.3 Market Dynamics
3.3.1 Market driver analysis
3.3.1.1 Presence of favorable government initiatives
3.3.1.2 Rising demand for agro-based products
3.3.1.3 Growing demand for synthetic biology
3.3.1.4 Declining prices of DNA sequencing
3.3.1.5 Growing healthcare expenditure boosting development of effective personalized diagnostic & therapeutic procedures for cancer
3.3.2 Market restraint analysis
3.3.2.1 Ethical & legal limitations
3.3.2.2 Risks associated with GM organisms and crops
3.3.2.3 Challenges associated with NGS implementation
3.4 Penetration and Growth Prospect Mapping for Technology, 2021
3.5 Market Share Analysis, 2021
3.6 Business Environment Analysis
3.6.1 SWOT Analysis; By factor (Political & Legal, Economic and Technological)
3.6.2 Porter’s Five Forces Analysis
CHAPTER 4 BIOTECHNOLOGY CATEGORIZATION: APPLICATION ESTIMATES & TREND ANALYSIS
4.1 Biotechnology Market: Application Movement Analysis
4.2 Health
4.2.1 Pre-COVID Segment Scenario
4.2.2 Post-COVID Segment Scenario
4.2.3 Global health Biotechnology market, 2018 - 2030 (USD Billion)
4.3 Food & Agriculture
4.3.1 Pre-COVID Segment Scenario
4.3.2 Post-COVID Segment Scenario
4.3.3 Global Food & Agriculture Biotechnology market, 2018 - 2030 (USD Billion)
4.4 Natural Resources & Environment
4.4.1 Pre-COVID Segment Scenario
4.4.2 Post-COVID Segment Scenario
4.4.3 Global Natural resources & environment Biotechnology market, 2018 - 2030 (USD Billion)
4.5 Industrial Processing
4.5.1 Pre-COVID Segment Scenario
4.5.2 Post-COVID Segment Scenario
4.5.3 Global Industrial processing Biotechnology market, 2018 - 2030 (USD Billion)
4.6 Bioinformatics
4.6.1 Pre-COVID Segment Scenario
4.6.2 Post-COVID Segment Scenario
4.6.3 Global Bioinformatics Biotechnology market, 2018 - 2030 (USD Billion)
4.7 Other Applications
4.7.1 Global Biotechnology market for applications, 2018 - 2030 (USD Billion)
CHAPTER 5 BIOTECHNOLOGY MARKET CATEGORIZATION: TECHNOLOGY ESTIMATES & TREND ANALYSIS
5.1 Biotechnology Market: Technology Movement Analysis
5.2 DNA Sequencing
5.2.1 Pre-COVID Segment Scenario
5.2.2 Post-COVID Segment Scenario
5.2.3 Global Biotechnology market for DNA Sequencing, 2018 - 2030 (USD Billion)
5.3 Nanobiotechnology
5.3.1 Pre-COVID Segment Scenario
5.3.2 Post-COVID Segment Scenario
5.3.3 Global Biotechnology market for Nanobiotechnology, 2018 - 2030 (USD Billion)
5.4 Tissue Engineering & Regeneration
5.4.1 Pre-COVID Segment Scenario
5.4.2 Post-COVID Segment Scenario
5.4.3 Global Biotechnology market for Tissue engineering and regeneration, 2018 - 2030 (USD Billion)
5.5 Fermentation
5.5.1 Pre-COVID Segment Scenario
5.5.2 Post-COVID Segment Scenario
5.5.3 Biopharmaceutical Manufacturing
5.5.4 Biopharmaceutical & Biotechnology Research
5.5.5 Others
5.5.6 Global Biotechnology market for Fermentation, 2018 - 2030 (USD Billion)
5.6 Cell-based Assays
5.6.1 Pre-COVID Segment Scenario
5.6.2 Post-COVID Segment Scenario
5.6.3 Global Biotechnology market for Cell-based assays, 2018 - 2030 (USD Billion)
5.7 PCR Technology
5.7.1 Pre-COVID Segment Scenario
5.7.2 Post-COVID Segment Scenario
5.7.3 Global Biotechnology market for PCR technology, 2018 - 2030 (USD Billion)
5.8 Chromatography
5.8.1 Pre-COVID Segment Scenario
5.8.2 Post-COVID Segment Scenario
5.8.3 Global Biotechnology market for Chromatography, 2018 - 2030 (USD Billion)
5.9 Other Technologies
5.9.1 Pre-COVID Segment Scenario
5.9.2 Post-COVID Segment Scenario
5.9.3 Global Biotechnology market for Other technologies, 2018 - 2030 (USD Billion)
CHAPTER 6 BIOTECHNOLOGY MARKET CATEGORIZATION: REGIONAL ESTIMATES & TREND ANALYSIS, BY APPLICATION & TECHNOLOGY
6.1 Biotechnology Share by Regional, 2021 & 2030
6.2 North America
6.2.1 U.S.
6.2.2 Canada
6.3 Europe
6.3.1Germany
6.3.2 U.K.
6.3.3 France
6.3.4 Italy
6.3.5 Spain
6.4 Asia-Pacific
6.4.1 Japan
6.4.2 China
6.4.3 India
6.4.4 South Korea
6.4.5 Australia
6.5 Latin America
6.5.1 Brazil
6.5.2 Mexico
6.6 Middle East and Africa (MEA)
6.6.1 South Africa
6.6.2 Saudi Arabia
CHAPTER 7 COMPETITIVE LANDSCAPE
7.1 Strategy Framework
7.2 Company Profiles
7.2.1 AstraZeneca
7.2.1.1 Company Overview
7.2.1.2 Financial Performance
7.2.1.3 Product Benchmarking
7.2.1.4 Strategic Initiatives
7.2.2 Gilead Sciences Inc.
7.2.2.1 Company Overview
7.2.2.2 Financial Performance
7.2.2.3 Product Benchmarking
7.2.2.4 Strategic Initiatives
7.2.3 Bristol-Myers Squibb
7.2.3.1 Company Overview
7.2.3.1.1 Celgene Corporation
7.2.3.2 Financial Performance
7.2.3.3 Product Benchmarking
7.2.3.4 Strategic Initiatives
7.2.4 Biogen
7.2.4.1 Company Overview
7.2.4.2 Financial Performance
7.2.4.3 Product Benchmarking
7.2.4.4 Strategic Initiatives
7.2.5 Abbott Laboratories
7.2.5.1 Company Overview
7.2.5.2 Financial Performance
7.2.5.3 Product Benchmarking
7.2.5.4 Strategic Initiatives
7.2.6 Amgen Inc.
7.2.6.1 Company Overview
7.2.6.2 Financial Performance
7.2.6.3 Product Benchmarking
7.2.6.4 Strategic Initiatives
7.2.7 Novo Nordisk A/S
7.2.7.1 Company Overview
7.2.7.2 Financial Performance
7.2.7.3 Product Benchmarking
7.2.7.4 Strategic Initiatives
7.2.8 Merck KGaA
7.2.8.1 Company Overview
7.2.8.2 Financial Performance
7.2.8.3 Product Benchmarking
7.2.8.4 Strategic Initiatives
7.2.9 Johnson & Johnson Services
7.2.9.1 Company Overview
7.2.9.2 Financial Performance
7.2.9.3 Product Benchmarking
7.2.9.4 Strategic Initiatives
7.2.10 Novartis AG
7.2.10.1 Company Overview
7.2.10.2 Financial Performance
7.2.10.3 Product Benchmarking
7.2.10.4 Strategic Initiatives
7.2.11 Sanofi
7.2.11.1 Company overview
7.2.11.1.1 Genzyme
7.2.11.2 Financial Performance
7.2.11.3 Product Benchmarking
7.2.11.4 Strategic Initiatives
7.2.12 F. Hoffmann-La Roche Ltd.
7.2.12.1 Company Overview
7.2.12.2 Financial Performance
7.2.12.3 Product Benchmarking
7.2.12.4 Strategic Initiatives
7.2.13 Pfizer Inc.
7.2.13.1 Company overview
7.2.13.2 Financial Performance
7.2.13.3 Product Benchmarking
7.2.13.4 Strategic Initiatives
7.2.14 Lonza
7.2.14.1 Company Overview
7.2.14.2 Financial Performance
7.2.14.3 Product Benchmarking
7.2.14.4 Strategic Initiatives
LIST OF TABLES
Table 1 Healthcare expenditure levels, 2018 - 2022
Table 2 Various approaches in regenerative medicine for dermatological use
Table 3 North America: Clinical studies using HCT for hematopoietic and non-hematopoietic conditions
Table 4 North America biotechnology market estimates & forecasts, by application, 2018 - 2030 (USD Billion)
Table 5 North America biotechnology market estimates & forecasts, by technology, 2018 - 2030 (USD Billion)
Table 6 U.S. biotechnology market estimates & forecasts, by application, 2018 - 2030 (USD Billion)
Table 7 U.S. biotechnology market estimates & forecasts, by technology, 2018 - 2030 (USD Billion)
Table 8 Canada biotechnology market estimates & forecasts, by application, 2018 - 2030 (USD Billion)
Table 9 Canada biotechnology market estimates & forecasts, by technology, 2018 - 2030 (USD Billion)
Table 10 Europe biotechnology market estimates & forecasts, by application, 2018 - 2030 (USD Billion)
Table 11 Europe biotechnology market estimates & forecasts, by technology, 2018 - 2030 (USD Billion)
Table 12 Germany biotechnology market estimates & forecasts, by application, 2018 - 2030 (USD Billion)
Table 13 Germany biotechnology market estimates & forecasts, by technology, 2018 - 2030 (USD Billion)
Table 14 U.K. biotechnology market estimates & forecasts, by application, 2018 - 2030 (USD Billion)
Table 15 U.K. biotechnology market estimates & forecasts, by technology, 2018 - 2030 (USD Billion)
Table 16 France biotechnology market estimates & forecasts, by application, 2018 - 2030 (USD Billion)
Table 17 France biotechnology market estimates & forecasts, by technology, 2018 - 2030 (USD Billion)
Table 18 Italy biotechnology market estimates & forecasts, by application, 2018 - 2030 (USD Billion)
Table 19 Italy biotechnology market estimates & forecasts, by technology, 2018 - 2030 (USD Billion)
Table 20 Spain biotechnology market estimates & forecasts, by application, 2018 - 2030 (USD Billion)
Table 21 Spain biotechnology market estimates & forecasts, by technology, 2018 - 2030 (USD Billion)
Table 22 Asia Pacific biotechnology market estimates & forecasts, by application, 2018 - 2030 (USD Billion)
Table 23 Asia Pacific biotechnology market estimates & forecasts, by technology, 2018 - 2030 (USD Billion)
Table 24 Japan biotechnology market estimates & forecasts, by application, 2018 - 2030 (USD Billion)
Table 25 Japan biotechnology market estimates & forecasts, by technology, 2018 - 2030 (USD Billion)
Table 26 Main monographs published in China
Table 27 China biotechnology market estimates & forecasts, by application, 2018 - 2030 (USD Billion)
Table 28 China biotechnology market estimates & forecasts, by technology, 2018 - 2030 (USD Billion)
Table 29 India biotechnology market estimates & forecasts, by application, 2018 - 2030 (USD Billion)
Table 30 India biotechnology market estimates & forecasts, by technology, 2018 - 2030 (USD Billion)
Table 31 South Korea biotechnology market estimates & forecasts, by application, 2018 - 2030 (USD Billion)
Table 32 South Korea biotechnology market estimates & forecasts, by technology, 2018 - 2030 (USD Billion)
Table 33 Australia biotechnology market estimates & forecasts, by application, 2018 - 2030 (USD Billion)
Table 34 Australia biotechnology market estimates & forecasts, by technology, 2018 - 2030 (USD Billion)
Table 35 Latin America: Current initiatives and opportunities
Table 36 Latin America biotechnology market estimates & forecasts, by application, 2018 - 2030 (USD Billion)
Table 37 Latin America biotechnology market estimates & forecasts, by technology, 2018 - 2030 (USD Billion)
Table 38 Brazil biotechnology market estimates & forecasts, by application, 2018 - 2030 (USD Billion)
Table 39 Brazil biotechnology market estimates & forecasts, by technology, 2018 - 2030 (USD Billion)
Table 40 Mexico biotechnology market estimates & forecasts, by application, 2018 - 2030 (USD Billion)
Table 41 Mexico biotechnology market estimates & forecasts, by technology, 2018 - 2030 (USD Billion)
Table 42 MEA biotechnology market estimates & forecasts, by application, 2018 - 2030 (USD Billion)
Table 43 MEA biotechnology market estimates & forecasts, by technology, 2018 - 2030 (USD Billion)
Table 44 South Africa biotechnology market estimates & forecasts, by application, 2018 - 2030 (USD Billion)
Table 45 South Africa biotechnology market estimates & forecasts, by technology, 2018 - 2030 (USD Billion)
Table 46 Saudi Arabia biotechnology market estimates & forecasts, by application, 2018 - 2030 (USD Billion)
Table 47 Saudi Arabia biotechnology market estimates & forecasts, by technology, 2018 - 2030 (USD Billion)?
Table 48List of companies evaluated for revenue modeling: Post-COVID market scenario
Table 49 Top 10 companies: Market value analysis, 2021 Vs 2022 (As of January) in USD billion
Table 50 NIH common fund awards for biomedical research
Table 51 Business grants for life science and biotech in Canada
Table 52 Applications of bioinformatics tools
Table 53 Types of cell-based assays and methods of quantification
Table 1 Healthcare expenditure levels, 2018 - 2022
Table 2 Various approaches in regenerative medicine for dermatological use
Table 3 North America: Clinical studies using HCT for hematopoietic and non-hematopoietic conditions
Table 4 North America biotechnology market estimates & forecasts, by application, 2018 - 2030 (USD Billion)
Table 5 North America biotechnology market estimates & forecasts, by technology, 2018 - 2030 (USD Billion)
Table 6 U.S. biotechnology market estimates & forecasts, by application, 2018 - 2030 (USD Billion)
Table 7 U.S. biotechnology market estimates & forecasts, by technology, 2018 - 2030 (USD Billion)
Table 8 Canada biotechnology market estimates & forecasts, by application, 2018 - 2030 (USD Billion)
Table 9 Canada biotechnology market estimates & forecasts, by technology, 2018 - 2030 (USD Billion)
Table 10 Europe biotechnology market estimates & forecasts, by application, 2018 - 2030 (USD Billion)
Table 11 Europe biotechnology market estimates & forecasts, by technology, 2018 - 2030 (USD Billion)
Table 12 Germany biotechnology market estimates & forecasts, by application, 2018 - 2030 (USD Billion)
Table 13 Germany biotechnology market estimates & forecasts, by technology, 2018 - 2030 (USD Billion)
Table 14 U.K. biotechnology market estimates & forecasts, by application, 2018 - 2030 (USD Billion)
Table 15 U.K. biotechnology market estimates & forecasts, by technology, 2018 - 2030 (USD Billion)
Table 16 France biotechnology market estimates & forecasts, by application, 2018 - 2030 (USD Billion)
Table 17 France biotechnology market estimates & forecasts, by technology, 2018 - 2030 (USD Billion)
Table 18 Italy biotechnology market estimates & forecasts, by application, 2018 - 2030 (USD Billion)
Table 19 Italy biotechnology market estimates & forecasts, by technology, 2018 - 2030 (USD Billion)
Table 20 Spain biotechnology market estimates & forecasts, by application, 2018 - 2030 (USD Billion)
Table 21 Spain biotechnology market estimates & forecasts, by technology, 2018 - 2030 (USD Billion)
Table 22 Asia Pacific biotechnology market estimates & forecasts, by application, 2018 - 2030 (USD Billion)
Table 23 Asia Pacific biotechnology market estimates & forecasts, by technology, 2018 - 2030 (USD Billion)
Table 24 Japan biotechnology market estimates & forecasts, by application, 2018 - 2030 (USD Billion)
Table 25 Japan biotechnology market estimates & forecasts, by technology, 2018 - 2030 (USD Billion)
Table 26 Main monographs published in China
Table 27 China biotechnology market estimates & forecasts, by application, 2018 - 2030 (USD Billion)
Table 28 China biotechnology market estimates & forecasts, by technology, 2018 - 2030 (USD Billion)
Table 29 India biotechnology market estimates & forecasts, by application, 2018 - 2030 (USD Billion)
Table 30 India biotechnology market estimates & forecasts, by technology, 2018 - 2030 (USD Billion)
Table 31 South Korea biotechnology market estimates & forecasts, by application, 2018 - 2030 (USD Billion)
Table 32 South Korea biotechnology market estimates & forecasts, by technology, 2018 - 2030 (USD Billion)
Table 33 Australia biotechnology market estimates & forecasts, by application, 2018 - 2030 (USD Billion)
Table 34 Australia biotechnology market estimates & forecasts, by technology, 2018 - 2030 (USD Billion)
Table 35 Latin America: Current initiatives and opportunities
Table 36 Latin America biotechnology market estimates & forecasts, by application, 2018 - 2030 (USD Billion)
Table 37 Latin America biotechnology market estimates & forecasts, by technology, 2018 - 2030 (USD Billion)
Table 38 Brazil biotechnology market estimates & forecasts, by application, 2018 - 2030 (USD Billion)
Table 39 Brazil biotechnology market estimates & forecasts, by technology, 2018 - 2030 (USD Billion)
Table 40 Mexico biotechnology market estimates & forecasts, by application, 2018 - 2030 (USD Billion)
Table 41 Mexico biotechnology market estimates & forecasts, by technology, 2018 - 2030 (USD Billion)
Table 42 MEA biotechnology market estimates & forecasts, by application, 2018 - 2030 (USD Billion)
Table 43 MEA biotechnology market estimates & forecasts, by technology, 2018 - 2030 (USD Billion)
Table 44 South Africa biotechnology market estimates & forecasts, by application, 2018 - 2030 (USD Billion)
Table 45 South Africa biotechnology market estimates & forecasts, by technology, 2018 - 2030 (USD Billion)
Table 46 Saudi Arabia biotechnology market estimates & forecasts, by application, 2018 - 2030 (USD Billion)
Table 47 Saudi Arabia biotechnology market estimates & forecasts, by technology, 2018 - 2030 (USD Billion)?
Table 48List of companies evaluated for revenue modeling: Post-COVID market scenario
Table 49 Top 10 companies: Market value analysis, 2021 Vs 2022 (As of January) in USD billion
Table 50 NIH common fund awards for biomedical research
Table 51 Business grants for life science and biotech in Canada
Table 52 Applications of bioinformatics tools
Table 53 Types of cell-based assays and methods of quantification
LIST OF FIGURES
Fig. 1 Market research process
Fig. 2 Information procurement
Fig. 3 Primary research
Fig. 4 Market research approaches
Fig. 5 Value chain-based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 Top 10 companies: Market revenue analysis, 2021 (USD Billion)
Fig. 9 Top 10 companies: Market capital analysis, 2021 (USD Billion)
Fig. 10 Top 10 companies: Market value analysis, 2021 Vs 2022 (As of January) in USD billion
Fig. 11 Market summary, 2021 (USD Billion)
Fig. 12 Market trends & outlook
Fig. 13 Market segmentation and scope
Fig. 14 Market driver relevance analysis (Current & future impact)
Fig. 15 Global financings for regenerative medicine, 2018
Fig. 16 DNA sequencing: Cost per MB, 2010 - August 2020
Fig. 17 Cost of per human genome, 2010 - August 2020
Fig. 18 Market restraint relevance analysis (Current & future impact)
Fig. 19 Side effects of GM foods
Fig. 20 Bottlenecks associated with implementation of NGS
Fig. 21 Penetration and growth prospect mapping for technology, 2021
Fig. 22 Company market share analysis, 2021
Fig. 23 SWOT Analysis, By Factor (Political & legal Economic and technological)
Fig. 24 Porter’s Five Forces Analysis
Fig. 25 Biotechnology market: Application outlook key takeaways
Fig. 26 Biotechnology market: Application movement analysis
Fig. 27 Advantages of biotechnology
Fig. 28 Gene therapy clinical trials number as of February 10, 2021
Fig. 29 Global health biotechnology market, 2018 - 2030 (USD Billion)
Fig. 30 Adoption of GM crops by region (millions of hectares)
Fig. 31 Trait enhancement in plants & crops through recombinant DNA technology
Fig. 32 Global food & agriculture biotechnology market, 2018 - 2030 (USD Billion)
Fig. 33 Global natural resources & environment biotechnology market, 2018 - 2030 (USD Billion)
Fig. 34 Global industrial processing biotechnology market, 2018 - 2030 (USD Billion)
Fig. 35 Global bioinformatics biotechnology market, 2018 - 2030 (USD Billion)
Fig. 36 Global biotechnology market for other applications, 2018 - 2030 (USD Billion)
Fig. 37 Biotechnology market: Technology outlook key takeaways
Fig. 38 Biotechnology market: Technology movement analysis
Fig. 39 Matrix of classification of the first, second, and third generation sequencing based on sequencing chemistry
Fig. 40 Global biotechnology market for DNA sequencing, 2018 - 2030 (USD Billion)
Fig. 41 Breakdown of nanomedicine products in phase III by therapeutic areas
Fig. 42 Types of therapeutic nanoparticles
Fig. 43 Global biotechnology market for nanobiotechnology, 2018 - 2030 (USD Billion)
Fig. 44 Global biotechnology market for tissue engineering and regeneration, 2018 - 2030 (USD Billion)
Fig. 45 Benefits of fermented food
Fig. 46 Global biotechnology market for fermentation, 2018 - 2030 (USD Billion)
Fig. 47 Global biotechnology market for cell-based assays, 2018 - 2030 (USD Billion)
Fig. 48 Global biotechnology market for PCR technology, 2018 - 2030 (USD Billion)
Fig. 49 Global biotechnology market for chromatography, 2018 - 2030 (USD Billion)
Fig. 50 Global biotechnology market for other technologies, 2018 - 2030 (USD Billion)
Fig. 51 Regional marketplace: Key takeaway
Fig. 52 Biotechnology regional outlook, 2021 & 2030
Fig. 53 North America biotechnology market, 2018 - 2030 (USD Billion)
Fig. 54 U.S. biotechnology market, 2018 - 2030 (USD Billion)
Fig. 55 Canada biotechnology market, 2018 - 2030 (USD Billion)
Fig. 56 Europe biotechnology market, 2018 - 2030 (USD Billion)
Fig. 57 Germany biotechnology market, 2018 - 2030 (USD Billion)
Fig. 58 U.K. biotechnology market, 2018 - 2030 (USD Billion)
Fig. 59 France biotechnology market, 2018 - 2030 (USD Billion)
Fig. 60 Italy biotechnology market, 2018 - 2030 (USD Billion)
Fig. 61 Spain biotechnology market, 2018 - 2030 (USD Billion)
Fig. 62 Asia-Pacific biotechnology market, 2018 - 2030 (USD Billion)
Fig. 63 Japan biotechnology market, 2018 - 2030 (USD Billion)
Fig. 64 China biotechnology market, 2018 - 2030 (USD Billion)
Fig. 65 India biotechnology market, 2018 - 2030 (USD Billion)
Fig. 66 South Korea biotechnology market, 2018 - 2030 (USD Billion)
Fig. 67 Australia biotechnology market, 2018 - 2030 (USD Billion)
Fig. 68 Latin America biotechnology market, 2018 - 2030 (USD Billion)
Fig. 69 Brazil biotechnology market, 2018 - 2030 (USD Billion)
Fig. 70 Mexico biotechnology market, 2018 - 2030 (USD Billion)
Fig. 71 Middle East & Africa (MEA) biotechnology market, 2018 - 2030 (USD Billion)
Fig. 72 South Africa biotechnology market, 2018 - 2030 (USD Billion)
Fig. 73 Saudi Arabia biotechnology market, 2018 - 2030 (USD Billion)
Fig. 74 Strategy framework
Fig. 75 Participant categorization
Fig. 1 Market research process
Fig. 2 Information procurement
Fig. 3 Primary research
Fig. 4 Market research approaches
Fig. 5 Value chain-based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 Top 10 companies: Market revenue analysis, 2021 (USD Billion)
Fig. 9 Top 10 companies: Market capital analysis, 2021 (USD Billion)
Fig. 10 Top 10 companies: Market value analysis, 2021 Vs 2022 (As of January) in USD billion
Fig. 11 Market summary, 2021 (USD Billion)
Fig. 12 Market trends & outlook
Fig. 13 Market segmentation and scope
Fig. 14 Market driver relevance analysis (Current & future impact)
Fig. 15 Global financings for regenerative medicine, 2018
Fig. 16 DNA sequencing: Cost per MB, 2010 - August 2020
Fig. 17 Cost of per human genome, 2010 - August 2020
Fig. 18 Market restraint relevance analysis (Current & future impact)
Fig. 19 Side effects of GM foods
Fig. 20 Bottlenecks associated with implementation of NGS
Fig. 21 Penetration and growth prospect mapping for technology, 2021
Fig. 22 Company market share analysis, 2021
Fig. 23 SWOT Analysis, By Factor (Political & legal Economic and technological)
Fig. 24 Porter’s Five Forces Analysis
Fig. 25 Biotechnology market: Application outlook key takeaways
Fig. 26 Biotechnology market: Application movement analysis
Fig. 27 Advantages of biotechnology
Fig. 28 Gene therapy clinical trials number as of February 10, 2021
Fig. 29 Global health biotechnology market, 2018 - 2030 (USD Billion)
Fig. 30 Adoption of GM crops by region (millions of hectares)
Fig. 31 Trait enhancement in plants & crops through recombinant DNA technology
Fig. 32 Global food & agriculture biotechnology market, 2018 - 2030 (USD Billion)
Fig. 33 Global natural resources & environment biotechnology market, 2018 - 2030 (USD Billion)
Fig. 34 Global industrial processing biotechnology market, 2018 - 2030 (USD Billion)
Fig. 35 Global bioinformatics biotechnology market, 2018 - 2030 (USD Billion)
Fig. 36 Global biotechnology market for other applications, 2018 - 2030 (USD Billion)
Fig. 37 Biotechnology market: Technology outlook key takeaways
Fig. 38 Biotechnology market: Technology movement analysis
Fig. 39 Matrix of classification of the first, second, and third generation sequencing based on sequencing chemistry
Fig. 40 Global biotechnology market for DNA sequencing, 2018 - 2030 (USD Billion)
Fig. 41 Breakdown of nanomedicine products in phase III by therapeutic areas
Fig. 42 Types of therapeutic nanoparticles
Fig. 43 Global biotechnology market for nanobiotechnology, 2018 - 2030 (USD Billion)
Fig. 44 Global biotechnology market for tissue engineering and regeneration, 2018 - 2030 (USD Billion)
Fig. 45 Benefits of fermented food
Fig. 46 Global biotechnology market for fermentation, 2018 - 2030 (USD Billion)
Fig. 47 Global biotechnology market for cell-based assays, 2018 - 2030 (USD Billion)
Fig. 48 Global biotechnology market for PCR technology, 2018 - 2030 (USD Billion)
Fig. 49 Global biotechnology market for chromatography, 2018 - 2030 (USD Billion)
Fig. 50 Global biotechnology market for other technologies, 2018 - 2030 (USD Billion)
Fig. 51 Regional marketplace: Key takeaway
Fig. 52 Biotechnology regional outlook, 2021 & 2030
Fig. 53 North America biotechnology market, 2018 - 2030 (USD Billion)
Fig. 54 U.S. biotechnology market, 2018 - 2030 (USD Billion)
Fig. 55 Canada biotechnology market, 2018 - 2030 (USD Billion)
Fig. 56 Europe biotechnology market, 2018 - 2030 (USD Billion)
Fig. 57 Germany biotechnology market, 2018 - 2030 (USD Billion)
Fig. 58 U.K. biotechnology market, 2018 - 2030 (USD Billion)
Fig. 59 France biotechnology market, 2018 - 2030 (USD Billion)
Fig. 60 Italy biotechnology market, 2018 - 2030 (USD Billion)
Fig. 61 Spain biotechnology market, 2018 - 2030 (USD Billion)
Fig. 62 Asia-Pacific biotechnology market, 2018 - 2030 (USD Billion)
Fig. 63 Japan biotechnology market, 2018 - 2030 (USD Billion)
Fig. 64 China biotechnology market, 2018 - 2030 (USD Billion)
Fig. 65 India biotechnology market, 2018 - 2030 (USD Billion)
Fig. 66 South Korea biotechnology market, 2018 - 2030 (USD Billion)
Fig. 67 Australia biotechnology market, 2018 - 2030 (USD Billion)
Fig. 68 Latin America biotechnology market, 2018 - 2030 (USD Billion)
Fig. 69 Brazil biotechnology market, 2018 - 2030 (USD Billion)
Fig. 70 Mexico biotechnology market, 2018 - 2030 (USD Billion)
Fig. 71 Middle East & Africa (MEA) biotechnology market, 2018 - 2030 (USD Billion)
Fig. 72 South Africa biotechnology market, 2018 - 2030 (USD Billion)
Fig. 73 Saudi Arabia biotechnology market, 2018 - 2030 (USD Billion)
Fig. 74 Strategy framework
Fig. 75 Participant categorization
